World's Best Scientists 2026 revealed!
VIEW LIST
Satoshi Morita

Satoshi Morita

Kyoto University
Japan

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 93 10678 10027 303 287 954 45308

Satoshi Morita publications per year

The chart shows the history of publications by Satoshi Morita between 1985 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Satoshi Morita published across 42 years, from 1985 to 2026, averaging 28.7 papers a year. Output peaked at 96 publications in 2013. 44 of the 1,205 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1985 to 2026. Vertical axis: number of publications, 0 to 96. Peak 96 publications in 2013. 1985: 2 publications 1986: 1 publication 1987: 1 publication 1988: 4 publications 1989: 8 publications 1990: 1 publication 1991: 0 publications 1992: 1 publication 1993: 1 publication 1994: 1 publication 1995: 1 publication 1996: 0 publications 1997: 1 publication 1998: 1 publication 1999: 0 publications 2000: 2 publications 2001: 2 publications 2002: 2 publications 2003: 7 publications 2004: 17 publications 2005: 16 publications 2006: 28 publications 2007: 17 publications 2008: 22 publications 2009: 33 publications 2010: 49 publications 2011: 58 publications 2012: 76 publications 2013: 96 publications 2014: 81 publications 2015: 83 publications 2016: 58 publications 2017: 64 publications 2018: 72 publications 2019: 47 publications 2020: 70 publications 2021: 72 publications 2022: 52 publications 2023: 62 publications 2024: 52 publications 2025: 43 publications 2026: 1 publication
1985 2026

1,205 publications in total across all disciplines

View publications per year as a table
Satoshi Morita: publications per year, 1985 to 2026
Year Publications
1985 2
1986 1
1987 1
1988 4
1989 8
1990 1
1991 0
1992 1
1993 1
1994 1
1995 1
1996 0
1997 1
1998 1
1999 0
2000 2
2001 2
2002 2
2003 7
2004 17
2005 16
2006 28
2007 17
2008 22
2009 33
2010 49
2011 58
2012 76
2013 96
2014 81
2015 83
2016 58
2017 64
2018 72
2019 47
2020 70
2021 72
2022 52
2023 62
2024 52
2025 43
2026 1
Total 1,205
Download as CSV

Satoshi Morita publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Satoshi Morita sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 941–960 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 954 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133 954
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Satoshi Morita D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Satoshi Morita sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839 93
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Satoshi Morita is a researcher affiliated with Kyoto University in Japan specializing in medicine, with a significant focus on oncology. Their scholarly work encompasses various subfields including oncology, pulmonary and respiratory medicine, cancer research, surgery, and molecular biology.

The main topics covered in their research include:

  • Lung Cancer Treatments and Mutations
  • Colorectal Cancer Treatments and Studies
  • Cancer Treatment and Pharmacology
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Gastric Cancer Management and Outcomes
  • Advanced Breast Cancer Therapies

Satoshi Morita has contributed to a number of research articles published in prominent journals. Some recent representative publications include:

  • Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, 2021, JAMA Oncology
  • International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1), 2021, Annals of Gastroenterological Surgery
  • Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma, 2021, Journal of Thoracic Oncology
  • Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC, 2021, Journal of Thoracic Oncology
  • Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR, 2022, Journal of Clinical Oncology

The frequent co-authors collaborating with Morita are:

  • Masakazu Toi
  • Norikazu Masuda
  • Shinji Ohno
  • Kunihiko Kobayashi
  • Toshimi Takano

The primary journals where Morita's work is published consist of:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • International Journal of Clinical Oncology
  • Cancer Research
  • Journal of Thoracic Oncology

This profile reflects an active research trajectory centered on critical aspects of cancer treatment and molecular oncology, particularly in lung and gastric cancers, as well as targeted therapies related to EGFR mutations. The scientist maintains a broad collaboration network and regularly publishes in high-impact clinical oncology journals.

Best Publications

  • Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

    Makoto Maemondo;Akira Inoue;Kunihiko Kobayashi;Shunichi Sugawara

  • Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

    Tetsuya Mitsudomi;Satoshi Morita;Yasushi Yatabe;Shunichi Negoro

  • Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

    Junzo Hamanishi;Masaki Mandai;Takafumi Ikeda;Manabu Minami

  • Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model

    Tetsuhiro Kikuchi;Asuka Morizane;Daisuke Doi;Hiroaki Magotani

  • First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy

    Akira Inoue;Kunihiko Kobayashi;Kazuhiro Usui;Makoto Maemondo

  • Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

    A. Inoue;K. Kobayashi;M. Maemondo;S. Sugawara

  • Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

    Haruhiro Saito;Tatsuro Fukuhara;Naoki Furuya;Kana Watanabe

  • Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

    Shuichi Hironaka;Shinya Ueda;Hirofumi Yasui;Tomohiro Nishina

  • Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.

    Yukio Hosomi;Satoshi Morita;Shunichi Sugawara;Terufumi Kato

  • Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.

    Manabu Morimoto;Kazushi Numata;Masaaki Kondou;Akito Nozaki

  • Sentinel Node Mapping for Gastric Cancer: A Prospective Multicenter Trial in Japan

    Yuko Kitagawa;Hiroya Takeuchi;Yu Takagi;Shoji Natsugoe

  • Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

    Jun Imagawa;Hideo Tanaka;Masaya Okada;Hirohisa Nakamae

  • Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.

    S. Miyatake;N. Miyake;H. Touho;A. Nishimura-Tadaki

  • Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.

    Yasuhide Yamada;Daisuke Takahari;Hiroshi Matsumoto;Hideo Baba

  • Determining the effective sample size of a parametric prior

    Satoshi Morita;Peter F. Thall;Peter Müller

  • Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)

    Kei Muro;Narikazu Boku;Yasuhiro Shimada;Akihito Tsuji

  • Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme.

    Shuichi Izumoto;Akihiro Tsuboi;Yoshihiro Oka;Tsuyoshi Suzuki

  • Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations

    Satoshi Morita;Isamu Okamoto;Kunihiko Kobayashi;Koichi Yamazaki

  • Frequency of and variables associated with the EGFR mutation and its subtypes

    Tomoaki Tanaka;Masaru Matsuoka;Akihisa Sutani;Akihiko Gemma

  • Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

    Kentaro Yamazaki;M. Nagase;H. Tamagawa;S. Ueda

Frequent Co-Authors

Masakazu Toi
Masakazu Toi Kyoto University
Yasuhiro Kodera
Yasuhiro Kodera Nagoya University
Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Isamu Okamoto
Isamu Okamoto Kyushu University
Narikazu Boku
Narikazu Boku St. Marianna University School of Medicine
Yasuo Ohashi
Yasuo Ohashi Chuo University
Itaru Endo
Itaru Endo Yokohama City University
Toshihiro Nukiwa
Toshihiro Nukiwa Tohoku University
Kei Muro
Kei Muro National Cancer Research Institute, UK
Hideo Baba
Hideo Baba Kumamoto University

External Links

Personal website of Satoshi Morita

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare careers isn’t limited to traditional, campus-based medical programs. Many students are finding flexibility and affordability through online degrees that lead to rewarding positions in the medical field. For registered nurses looking to advance, consider some of the cheapest accredited online rn to bsn programs to earn your bachelor’s degree without heavy financial pressure.

If you’re interested in the nurse practitioner route but don’t already have a nursing background, direct entry np programs for non nurses online offer a faster way to transition into advanced nursing roles.

Those starting out in nursing can check out online adn programs, which generally have lower barriers to entry and prepare students for RN licensure efficiently.

Interested in the administrative side of healthcare? Choose from the best online medical billing and coding schools to start a flexible, in-demand career supporting medical practices and health systems.

Best Scientists Citing Satoshi Morita

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 95

Tony Mok

Tony Mok

Chinese University of Hong Kong

Publications: 88

Kazuhiko Nakagawa

Kazuhiko Nakagawa

Kindai University

Publications: 82

James Chih-Hsin Yang

James Chih-Hsin Yang

National Taiwan University

Publications: 81

Yasuhiro Kodera

Yasuhiro Kodera

Nagoya University

Publications: 76

Isamu Okamoto

Isamu Okamoto

Kyushu University

Publications: 71

Tetsuya Mitsudomi

Tetsuya Mitsudomi

Kindai University

Publications: 70

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 62

Caicun Zhou

Caicun Zhou

Tongji University

Publications: 56

Li Zhang

Li Zhang

Sun Yat-sen University

Publications: 52

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 51

Lecia V. Sequist

Lecia V. Sequist

Harvard University

Publications: 51

Kazuto Nishio

Kazuto Nishio

Kindai University

Publications: 47

Yuko Kitagawa

Yuko Kitagawa

Keio University

Publications: 47

Myung-Ju Ahn

Myung-Ju Ahn

Sungkyunkwan University

Publications: 46

Haruo Sugiyama

Haruo Sugiyama

Osaka University

Publications: 46

Trending Scientists

Jin Kon Kim

Jin Kon Kim

Pohang University of Science and Technology

Massimo Nepi

Massimo Nepi

University of Siena

Shabir H. Wani

Shabir H. Wani

Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir

Peter Noack

Peter Noack

Friedrich Schiller University Jena

Nigel Metcalfe

Nigel Metcalfe

Durham University

Edward L. Murphy

Edward L. Murphy

University of California, San Francisco

Warren Barrash

Warren Barrash

Boise State University

Matthew W. Kreuter

Matthew W. Kreuter

Washington University in St. Louis

JD Jan Janssen

JD Jan Janssen

Eindhoven University of Technology

Alfredo Vaccaro

Alfredo Vaccaro

University of Sannio

Austin Tate

Austin Tate

University of Edinburgh

Andreas Marx

Andreas Marx

University of Konstanz

Gregory W. Peterson

Gregory W. Peterson

United States Army Research Laboratory

Jean-François Halet

Jean-François Halet

University of Rennes

Luca Persani

Luca Persani

University of Milan

Elaine M. Dennison

Elaine M. Dennison

University of Southampton

Related Medicine Rankings & Guides

2027 Best Online MSN Family Nurse Practitioner Programs

2027 Best Online MSN Family Nurse Practitioner Programs
2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 Easiest DNP Programs

2027 Easiest DNP Programs
2027 Easiest RN-to-MSN Online Programs to Get Into

2027 Easiest RN-to-MSN Online Programs to Get Into
2027 Best Self-Paced Online RN-to-BSN Degree Programs

2027 Best Self-Paced Online RN-to-BSN Degree Programs
2027 How Much Do Medical Assistant Programs & Certifications Cost?

2027 How Much Do Medical Assistant Programs & Certifications Cost?
2027 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs
2027 Most Affordable Master’s Degrees in Healthcare Administration

2027 Most Affordable Master’s Degrees in Healthcare Administration
September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs

September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs
2027 Best Online CAHME-Accredited MHA Programs

2027 Best Online CAHME-Accredited MHA Programs
2027 Best Online Medical Assistant Associate Degree Programs

2027 Best Online Medical Assistant Associate Degree Programs
2027 Is Nursing School Worth It?

2027 Is Nursing School Worth It?
2027 Best Online Exercise Science Degree Programs

2027 Best Online Exercise Science Degree Programs
2027 Most Affordable Online MSN in Nurse Executive Leadership Programs

2027 Most Affordable Online MSN in Nurse Executive Leadership Programs
2027 Best Online BSN to FNP Programs

2027 Best Online BSN to FNP Programs
2027 Best Online Nurse Leadership DNP Programs

2027 Best Online Nurse Leadership DNP Programs
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
September 2027 Best Online Master’s of Science in Nursing Degree Programs

September 2027 Best Online Master’s of Science in Nursing Degree Programs
2027 Best Nurse Practitioner Programs in Illinois – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Illinois – Accredited Schools Online & Campus
2027 Most Affordable Online LPN to RN Degree Programs

2027 Most Affordable Online LPN to RN Degree Programs
2027 Best Online Sonography Programs

2027 Best Online Sonography Programs

Recently Published Articles

2027 Cheapest Addiction Counseling Degree Programs for Working Adults

2027 Cheapest Addiction Counseling Degree Programs for Working Adults
2027 Admission Requirements for Philosophy Degree Programs

2027 Admission Requirements for Philosophy Degree Programs
2027 How to Become a Medical Biller & Coder in Port St. Lucie, FL: Education Requirements & Certification

2027 How to Become a Medical Biller & Coder in Port St. Lucie, FL: Education Requirements & Certification
2027 Online Secondary Education Bachelor's Degree Programs With Asynchronous Classes

2027 Online Secondary Education Bachelor's Degree Programs With Asynchronous Classes
2027 Cheapest and Shortest Online Clinical Mental Health Counseling Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Clinical Mental Health Counseling Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Online Sociology Bachelor's Degree Programs With Open Enrollment

2027 Online Sociology Bachelor's Degree Programs With Open Enrollment
2027 How to Become a Licensed Pharmacist in Mississippi

2027 How to Become a Licensed Pharmacist in Mississippi
2027 How to Become a Kindergarten Teacher in Texas

2027 How to Become a Kindergarten Teacher in Texas
2027 English as Second Language Degrees Explained: Are They Classified as Professional Degrees?

2027 English as Second Language Degrees Explained: Are They Classified as Professional Degrees?
2027 Is Physical Therapy Assistant a Hard Major? What Students Should Know

2027 Is Physical Therapy Assistant a Hard Major? What Students Should Know
2027 Hybrid vs Fully Online Sociology Bachelor's Degree Programs

2027 Hybrid vs Fully Online Sociology Bachelor's Degree Programs
2027 Nursing Career Paths: 11 Least Stressful Nursing Jobs to Explore

2027 Nursing Career Paths: 11 Least Stressful Nursing Jobs to Explore
2027 Most Affordable Online Master’s in Data Science Programs

2027 Most Affordable Online Master’s in Data Science Programs
2027 FNP-BC vs. FNP-C: Difference Between Nurse Practitioner Certifications

2027 FNP-BC vs. FNP-C: Difference Between Nurse Practitioner Certifications
2027 Licensing Exams Required After Completing a Human Services Degree Program

2027 Licensing Exams Required After Completing a Human Services Degree Program
2027 How Many Credits Can You Transfer Into a Nursing Education Degree Program?

2027 How Many Credits Can You Transfer Into a Nursing Education Degree Program?
2027 Best Accelerated RN to BSN to MSN Online Bridge Programs

2027 Best Accelerated RN to BSN to MSN Online Bridge Programs
2027 How to Become a Licensed Counselor (LPC) in Colorado

2027 How to Become a Licensed Counselor (LPC) in Colorado
2027 What Does a Family Law Paralegal Do: Responsibilities, Requirements, and Salary

2027 What Does a Family Law Paralegal Do: Responsibilities, Requirements, and Salary
2027 Online Social Work Leadership Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Social Work Leadership Doctorate Programs for Experienced Professionals Without Research Backgrounds
2027 Entry-Level Jobs With a Criminal Justice Degree

2027 Entry-Level Jobs With a Criminal Justice Degree